A disproportionality analysis of insulin glargine in the overall population and in pregnant women using the FDA adverse event reporting system (FAERS) database
This study has identified unexpected AE signals associated with IG in pregnant women. Our research provides valuable evidence for the clinical application of IG, offers real-world data to support safe medication practices during pregnancy, and establishes a foundation for further clinical investigations.
Authors
- Zhongwen Yuan (ORCID: https://orcid.org/0000-0002-5082-7909)
- Zhengrong Mei
- Shaozhi Liu (ORCID: https://orcid.org/0000-0002-0868-8618)
- Shengying Shi (ORCID: https://orcid.org/0000-0002-0153-4691)
- Jinjin Yin (ORCID: https://orcid.org/0000-0001-5664-2123)
- Jun Xu
- Yanhong Deng (ORCID: https://orcid.org/0000-0003-1567-4158)
Institutions
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1371/journal.pone.0331489
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29